Kaoru Takasaki, MD
About Kaoru Takasaki, MD
Titles
Attending Physician
Instructor of Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Certifications
Pediatrics – American Board of Pediatrics
Awards and Honors
2021-present, Ken Mizuno Fund in Hematology
2020-present, NIH/NHLBI T32 Pediatric Hematology Research Training Program
2018-2019, Stanford Pediatrics Resident Research Grant
2013-2016, Japanese Medical Society of America, Nishioka Foundation Scholarship
2013, Alex’s Lemonade Stand Foundation (ALSF), Pediatric Oncology Student Training (POST) Grant
2010, magna cum laude, Harvard College
Leadership and Memberships
Memberships in Professional Organizations
2021-present, American Association for Cancer Research
2021-present, American Society of Clinical Oncology
2021-present, American Society of Pediatric Hematology/Oncology
2019-present, American Board of Pediatrics
2019-present, Children’s Oncology Group
2018-present, American Society of Hematology
Education & training
Medical Degree
MD - Yale School of Medicine, New Haven, CT
Residency
Pediatrics - Stanford, Palo Alto, CA
Fellowship
Pediatric Hematology/Oncology - Children’s Hospital of Philadelphia, Philadelphia, PA
Publications
Publications
2022
Takasaki K, Hehir D, Raffini L, Samelson-Jones BJ, Shih E, Dain AS. Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage. Pediatr Blood Cancer. 2022 Jun;69(6):e29484. Epub 2021 Nov 22.
2016
Takasaki K, Diaz-Stransky A, Miller G. Psychogenic Nonepileptic Seizures: Diagnosis, Management, and Bioethics. Pediatric Neurology. 2016 Apr;pii: S0887-8994(15)30402-1.
2015
Greenfeld H*, Takasaki K*, Walsh MJ*, Ersing I, Bernhardt K, Ma Y, Fu B, Ashbaugh CW, Cabo J, Mollo SB, Zhou H, Li S, Gewurz BE. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation. PLoS Pathogens. 2015 May;11(5): e1004890.
2014
Zhao B, Barrera LA, Ersing I, Willox B, Schmidt SC, Greenfeld H, Zhou H, Mollo SB, Shi TT, Takasaki K, Jiang S, Cahir-McFarland E, Kellis M, Bulyk ML, Kieff E, Gewurz BE. The NF-κB genomic landscape in lymphoblastoid B cells. Cell Reports. 2014 Sep;8(5): 1595-1606.
2013
Zhou X, Gewurz BE, Ritchie JM, Takasaki K, Greenfeld H, Kieff E, Davis BM, Waldor MK. A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation. Cell Reports. 2013 May;3(5):1690-1702.
2012
Gewurz BE, Towfic F, Mar JC, Shinners NP, Takasaki K, Zhao B, Cahir-McFarland ED, Quackenbush J, Xavier RJ, Kieff E. Genome-wide siRNA screen for mediators of NF-κB activation. PNAS. 2012 Feb;109(7): 2467-2472.
2011
Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY, Cahir-McFarland E, Quackenbush J, Kieff E. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. Journal of Virology. 2011 July;85(13): 6764-6773.
Editorials, Reviews, Chapters
2022
Takasaki K, Chou ST. Rh Incompatibility. Ferri’s Clinical Advisor 2023. Providence, RI: Elsevier, 2022 (In press).
Takasaki K, Chou ST. Red cell genotyping: Real world use. Transfus Med. 2022 Jun;32(3):185-186.
2021
Takasaki K, Chou S. Rh Incompatibility. Ferri’s Clinical Advisor 2022. Providence, RI: Elsevier, 2021.